← Open Payments lookup

JOHN VAETH: Open Payments

NPI 1992848345 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465,679 in 578 payments from 8 companies in 2025. Trend: 2023 $408,796 · 2024 $411,634 · 2025 $465,679

Speaker / faculty: $261,496Honoraria: $106,425Travel & lodging: $82,814Food & beverage: $11,425Consulting: $3,520
CompanyPaymentsAmount
ABBVIE INC.206$155,917
Axsome Therapeutics, Inc.167$128,273
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)124$112,455
Vanda Pharmaceuticals Inc.63$50,875
Otsuka America Pharmaceutical, Inc.14$18,056
Otsuka Pharmaceutical Development & Commercialization, Inc.2$60
Tris Pharma Inc1$27
Lundbeck LLC1$16

Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, Dyanavel XR.

Industry payments across MD — which companies pay providers there.